Tag Archives: sny

Eli Lilly’s Basal Insulin Outperforms Lantus In Trial

Big pharma Eli Lilly (LLY) said Monday that its drug candidate reduced blood sugar in diabetics more than another leading treatment. The company’s stock rose a fraction on the stock market today. The phase-three clinical trial showed Lilly’s basal insulin peglispro (BIL) outperformed Sanofi’s (SNY) Lantus in patients with type 2 diabetes, though it did not yet release the exact numbers. Lilly also said patients on BIL showed less weight gain than

Amgen Stock Gets Bump Up On Cholesterol Drug Data

Amgen (AMGN) stock was up 2.5% in afternoon trading on the stock market today after the company presented five studies on its new cholesterol drug over the weekend. Results eased safety concerns raised earlier in the month. Competitors Regeneron (REGN), Sanofi (SNY), Pfizer (PFE) and Bristol-Myers Squibb (BMY) also presented data, but their shares were up a fraction or flat Monday afternoon. At the American College of Cardiology meeting, Amgen

New Cholesterol Fighters To Take Center Stage At ACC

In recent decades, high cholesterol has been Big Pharma’s gravy train. The statins, oral drugs that lower “bad” cholesterol, turned into the best-selling drugs in history, with Pfizer’s Lipitor peaking at nearly $14 billion in 2006 sales. Now, however, all the statins have gone off-patent or are about to. So Pfizer (PFE) and a passel of other companies — led by Amgen (AMGN), Regeneron (REGN) and Regeneron’s partner Sanofi (SNY) — are turning to a